Integrating liver endpoints in clinical trials of cardiovascular and kidney disease
Year: 2024
Type: article
Source: Nature Medicine
Institutions: Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, University of Mississippi, Baylor Scott & White Research Institute, University of California, Berkeley, University of Oxford
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402199854
